LGALS8, also known as prostate-specific membrane antigen (PCTA1), is an additional prostatespecific antigen that is overexpressed only in malignant tumors and therefore is a more specific identifier of malignancies. It is a member of the galectin gene family which mediates both cell-cell and cell matrix interactions in a manner similar to the selectin subgroup of C-type lectins.